VITAFORT INTERNATIONAL CORP
10QSB, 1999-11-15
BAKERY PRODUCTS
Previous: HISTORIC PRESERVATION PROPERTIES 1990 LP TAX CREDIT FUND, 10-Q, 1999-11-15
Next: DYNAGEN INC, 10QSB, 1999-11-15










































<PAGE>
                     SECURITIES AND EXCHANGE COMMISSION
                          WASHINGTON, D.C.  20549

                               FORM 10-QSB


         [x] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
                OF THE SECURITIES AND EXCHANGE ACT OF 1934

              For the quarterly period ended September 30, 1999


            [  ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
                 OF THE SECURITIES AND EXCHANGE ACT OF 1934

                 For the transition period from ________ to ________

                            Commission File Number 0-18438


                     VITAFORT INTERNATIONAL CORPORATION
              (Exact name of Registrant as specified in its charter)

	          DELAWARE	                  68-0110509
	(State or other Jurisdiction of	(I.R.S. Employer
	incorporation or organization)	Identification Number)

           1800 Avenue of the Stars, Suite 480, Los Angeles, CA 90067
                  (Address of principal executive offices)
                                  (Zip Code)


		                      (310) 552-6393
               (Registrant's telephone number, including area code)


Check whether the issuer (1) has filed all reports required to be filed by
section 13 or 15(d) of the Exchange Act of 1934 of during the preceding
twelve months ended December 31, 1997 (or for such shorter period that the
Registrant was required to file such reports) and (2) has been subject to
such filing requirements for the past ninety days.

	                   Yes: 	X		No:

The number of shares of the Registrant's Common Stock, par value $.0001 per
share outstanding on November __, 1999 is ______________.









                                      1
<PAGE>
                       VITAFORT INTERNATIONAL CORPORATION

                                     CONTENTS


PART 1 - FINANCIAL INFORMATION

_____________________________________________________________________________
<TABLE>
<CAPTION>

<S>         <C>
ITEM 1.	Consolidated Financial Statements:

            Balance Sheets - September 30, 1999 and December 31, 1998 	3

		Statements of Operations -
		Three-Month Periods Ended September 30, 1999 and 1998

            Nine-Month Periods Ended September 30, 1999 and 1998

		Statement of Stockholders' Equity (Deficit) -
		Nine Month Period Ended September 30, 1999

		Statements of Cash Flows -
		Nine-Month Periods Ended September 30, 1999 and 1998

		Notes to the Financial Statements

ITEM 2.	Management's Discussion and Analysis of Financial Condition
		and Results of Operations



PART II - OTHER INFORMATION



ITEM 1.	Legal Proceedings
ITEM 5.	Other Information
Signature














                                       2
<PAGE>

                VITAFORT INTERNATIONAL CORPORATION & SUBSIDIARIES
                       CONSOLIDATED BALANCE SHEET
              As of  September 30, 1999 and December 31, 1998

</TABLE>
<TABLE>
<CAPTION>
ASSETS
                                              September 30,
                                                   1999      December 31,
                                               (Unaudited)       1998
                                               ----------    -----------
<S>                                            <C>           <C>
Current assets
Cash and cash equivalents                      $1,327,033    $   903,649
Marketable securities                              55,000        250,000
Accounts receivable, less allowance
 for doubtful accounts of $82,106                 538,441        929,006
Other Receivables                                  96,659               -
Inventories                                       519,749        196,603
Prepaid expenses and other current assets         544,084        132,509
                                               ----------    -----------
Total Current Assets                            3,080,966      2,411,767
Equipment
Manufacturing equipment                           110,824         19,881
Furniture and equipment                           105,160        105,160
Computer equipment                                209,574        209,574
                                               ----------    -----------
                                                  425,558        334,615
Less accumulated depreciation                    (323,039)      (271,411)
                                               ----------    -----------
                                                  102,519         63,204
Other Assets
Intangible assets, net of accumulated
  amortization of $121,224 and $66,236            781,148        911,684
Other assets                                          875            875
                                               ----------    -----------
    Total Other Assets                            782,023        912,559
                                               ----------    -----------
                                               $3,965,508    $ 3,387,530
                                               ==========    ===========
</TABLE>
See accompanying notes to consolidated financial statements













                                        3
<PAGE>
            VITAFORT INTERNATIONAL CORPORATION & SUBSIDIARIES
                      CONSOLIDATED BALANCE SHEET
            As of September 30, 1999 and December 31, 1998
<TABLE>
<CAPTION>
                 LIABILITIES AND STOCKHOLDERS' EQUITY
                                                  September 30,
                                                      1999       December 31,
                                                   (Unaudited)        1998
                                                 ------------     -----------
<S>                                              <C>              <C>
Current liabilities
Notes payable - bank                                              $   283,689
Notes payable - others                              $1,790,493        958,724
Convertible notes payable                              375,000        600,000
Accounts payable                                       825,869      1,054,079
Accrued expenses                                       385,755        130,303
                                                 -------------    -----------

    Total Current Liabilities                        3,377,118      3,026,795
Long-term debt                                             -        2,065,000

Minority interest                                      501,165              -

Stockholders' equity
Series B, 10% Cumulative Convertible
Preferred Stock, $.01 par value; authorized
110,000 shares; issued and outstanding
1,000 shares, aggregate liquidation
preference of $50,000                                       10             10
Series C, Convertible Preferred Stock, $.01
par value; authorized 450 shares; issued
and outstanding 50 shares, aggregate
liquidation preference of $50,000                            1              1
Common stock, $.0001 par value; authorized
30,000,000 shares; issued and outstanding
17,517,288 and 12,056,428 shares                         1,752          1,206
Additional paid-in-capital                          25,039,134     24,064,868
Accumulated deficit                                (24,953,672)   (25,770,350)
                                                 -------------    -----------

    Total Stockholders' Equity                          87,225     (1,704,265)
                                                 ------------     -----------

Total Liabilities & Stockholders' Equity         $   3,965,508    $ 3,387,530
                                                  ============     ==========
</TABLE>

See accompanying notes to consolidated financial statements






                                        4
<PAGE>
          VITAFORT INTERNATIONAL CORPORATION AND SUBSIDIARIES
              CONSOLIDATED STATEMENTS OF OPERATIONS
                           (Unaudited)
<TABLE>
<CAPTION>
                                                    Three Months Ended
                                                    September 30,
                                                       1999         1998
                                                    ---------   ----------
<S>                                                 <C>         <C>
Net revenues                                        $ 738,437   $  805,511

Cost of sales                                         524,677      403,092
                                                    ---------   ----------
      Gross profit                                    213,761      402,419
Operating expenses
  Research and development                             34,159      140,667
  Sales and marketing                                 496,873      621,708
  General and administrative                          520,616      647,295
                                                    ---------   ----------
    Total operating expenses                        1,051,647    1,409,670

    Loss from operations                             (837,887)  (1,007,251)

Other income (expense)
  Other income (expense)                              145,073          385
  Interest income                                       6,000        2,834
  Other income - forgiveness                        1,478,239            -
  Interest expense                                    (36,871)     (51,296)
                                                    ----------  -----------
    Total other income (expense)                    1,599,276      (48,077)

    Income (loss)  before income tax expense          761,389   (1,055,328)

State income tax expense                                 (820)         207
                                                    ----------  -----------
Net income (loss)                                     762,209   (1,055,535)
Deemed dividend to preferred shareholders                 -       (279,250)
                                                    ----------  -----------
Net income (loss) allocable to common
  shareholders                                        762,209   (1,334,785)
                                                    ==========  ===========
Basic and diluted net income (loss) per
  common share                                        $  0.05    $   (0.18)
                                                     ========    ==========
Basic and diluted  weighted average shares
  of common stock                                    14,359,168   7,547,094
                                                     =========    =========
</TABLE>

See accompanying notes to consolidated financial statements




                                        5
<PAGE>
          VITAFORT INTERNATIONAL CORPORATION AND SUBSIDIARIES
               CONSOLIDATED STATEMENTS OF OPERATIONS
                          (Unaudited)
<TABLE>
<CAPTION>
                                                          Nine Months Ended
                                                          September 30,
                                                           1999          1998
                                                       -----------  ---------
<S>                                                    <C>         <C>
Net revenues                                           $1,851,685  $1,555,505

Cost of sales                                           1,161,653     951,407
                                                       ----------    --------
      Gross profit                                        690,033     604,098
Operating expenses
  Research and development                                 56,315     280,251
  Sales and marketing                                   1,279,950   1,368,052
  General and administrative                            1,394,384   2,121,027
                                                       ----------  ----------
    Total operating expenses                            2,730,648   3,769,330

    Loss from operations                               (2,040,616 ) 3,165,232)
Other income (expense)
  Other income (expense)                                1,345,073     (60,000)
  Interest income                                           6,498      38,851
  Minority interest in net loss of
    Consolidated subsidiary                                 6,835
  Other income-forgiveness                              1,751,790          -
  Interest expense                                       (253,723)   (149,202)
                                                       ----------  ----------
    Total other income (expense)                        2,856,474    (170,351)

    Income (loss)  before income tax expense              815,858  (3,335,583)

State income tax expense                                     (820)      3,407
                                                       ----------- ----------
Net income (loss)                                         816,678  (3,338,990)
Deemed dividend to preferred shareholders
  (Note 10)                                                   -      (629,148)
                                                       ----------- ----------
Net income (loss) allocable to common
  shareholders                                            816,678  (3,968,138)
                                                       =========== ==========
Basic and diluted net income (loss) per
  common share                                           $  0.06    $   (0.55)
                                                       ===========  ==========
Basic and diluted  weighted average shares of
  of common stock                                       14,785,893   7,178,791
                                                       ===========   =========
</TABLE>
See accompanying notes to consolidated financial statements



                                        6
<PAGE>
         VITAFORT INTERNATIONAL CORPORATION AND SUBSIDIARIES
          CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited)
                Nine Months Ended June 30, 1999
<TABLE>
<CAPTION>
                             Series B Convertible        Series C Convertible
                             Preferred Stock              Preferred Stock
                             Shares         Amount            Shares
Amount
                             -----------    ----------      -----------   ---
<S>                          <C>            <C>           <C>            <C>
Balance, January 1, 1999           1,000   $       10              50  $  1
Exercise of stock options
Net Income / (Loss)
                              ----------   ----------      ----------  -----
Balance, June 30, 1999             1,000   $       10              50  $  1
                               ==========  ===========      ==========  =====
</TABLE>
<TABLE>
<CAPTION>
                                                            Additional
                              Common Stock                    Paid-in
                                 Shares         Amount        Capital
                               -----------   -----------   ------------
<S>                          <C>            <C>           <C>
Balance, January 1, 1999          12,056,428   $    1,206    $24,064,868
Exercise of stock options          5,460,860          546        974,812
Net Income / (Loss)
                               ------------  -----------   ------------
Balance, June 30, 1999            17,517,288   $    1,410    $25,039,134
                                ===========    ==========    ===========
</TABLE>
<TABLE>
<CAPTION>
                                Accumulated
                                    Deficit         Total
                                -----------   -----------
<S>                             <C>            <C>
Balance, January 1, 1999        (25,770,350)   (1,704,265)
Exercise of stock options                         974,812
Net Income / (Loss)                 816,678       831,562
                               ------------   -----------
Balance, June 30, 1999          (24,953,672)       87,225
                               ============   ===========
</TABLE>
See accompanying notes to consolidated financial statements









                                         7
<PAGE>
            VITAFORT INTERATIONAL CORPORTION & SUBSIDIARIES
             CONSOLIDATED STATEMENTS OF CASH FLOWS
<TABLE>
<CAPTION>
                                                       Nine Months Ended
                                                        September 30,
                                                        1999        1998
                                                    -----------   -----------
<S>                                                 <C>           <C>
Increase (Decrease) in Cash and Cash
  Equivalents
Cash flows from operating activities:
Net income(loss)                                    $  831,563   $(3,338,990)
Depreciation and amortization                          119,798       136,207
Prior year adjustment                                 (130,319)
Stock issued for services                                  -         214,706
Changes in operating assets and liabilities:
(Increase) decrease in:
Accounts receivable,  net                              390,566       105,500
Inventories                                           (214,547)     (332,522)
Prepaid expenses and other current assets             (309,472)       57,983
Other assets                                           (96,659)         (875)
Increase (decrease) in:
Accounts payable                                      (369,945)      503,584
Accrued expenses                                       240,452      (284,188)
                                                    -----------  ------------
Cash and cash equivalents used in operating
  activities                                           461,436    (2,938,595)

Cash flows from investing activities:
Proceeds from disposal of equipment                        -
Purchase of equipment                                  (90,942)      (42,392)
Advances to related parties                                -              -
Advances to Global International                            (0)           -
Product acquisition costs                                  -              -
Advances to related parties                                             (468)
Advances to Global International                                    (285,385)
Cash acquired through sale of marketable
 securities                                            195,000             -
Cash acquired through acquisition of Global
 International Sourcing                                    -           75,462
                                                    -----------  ------------
Cash and cash equivalents used in investing
 activities                                            104,058      (252,783)
</TABLE>










                                       8
<PAGE>
            VITAFORT INTERATIONAL CORPORTION & SUBSIDIARIES
             CONSOLIDATED STATEMENTS OF CASH FLOWS - Continued
<TABLE>
<CAPTION>
                                                      Nine Months Ended
                                                        September 30,
                                                        1999        1998
                                                    -----------   -----------
<S>                                                 <C>           <C>
Cash flows from financing activities:
Proceeds from issuance of stock                      1,098,812        499,000
Proceeds from notes payable, short term                606,769        684,363
Proceeds from APIC                                     500,000
Repayments of notes payable                         (2,348,690)        36,363
                                                    -----------   -----------
Cash and cash equivalents provided by
  financing activities                                (143,109)     1,219,726

Increase (decrease) in cash and cash
  equivalents                                          422,385    (1,971,652)
Cash and cash equivalents, beginning of period         903,649      2,199,036
                                                    ----------   ------------
Cash and cash equivalents, end of period            $1,326,034    $   227,384
                                                    ==========    ===========
Supplemental  disclosure of cash flow
  information
Cash paid during the period for:
Interest                                            $  293,424    $   149,202
Income taxes                                        $      820    $   (3,407)

Supplemental disclosure of non-cash operating,
  investing, and financing activities
Stock issued for accounts payable                                 $   519,692
Stock issued for prepaid consulting services                      $   102,602
Stock issued for acquisition of marketing                         $    43,125
  contract
Acquisition of Global International Sourcing:
Assets acquired, net of cash                        $        -    $   535,786
Liabilities assumed, including $522,328 due
  to Vitafort                                       $        -    $   829,461
</TABLE>



See accompanying notes to consolidated financial statements










                                        9
<PAGE>
               VITAFORT INTERNATIONAL CORPORATION AND SUBSIDIARIES
                  NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                                     (Unaudited)

NOTE 1 - GENERAL

The unaudited consolidated financial statements have been prepared on
the same basis as the audited consolidated financial statements and, in the
opinion of management, reflect all adjustments (consisting of normal
recurring adjustments) necessary for a fair presentation for each of the
periods presented.  The results of operations for interim periods are not
necessarily indicative of results to be achieved for full fiscal years.

As contemplated by the Securities and Exchange Commission (SEC) under
item 310(b) of Regulation S-B, the accompanying consolidated financial
statements and related footnotes do not contain certain information that will
be included in the Company's annual consolidated financial statements and
footnotes thereto.  For further information, refer to the consolidated
financial statements and related footnotes included in the fiscal 1998
filing.

The Company is presently engaged in formulating, marketing and distributing
fat-free, low fat and reduced fat foods.

NOTE 2 -- SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES:

(a) The accompanying consolidated financial statements include the
accounts of the Company and its subsidiaries.  All material intercompany
accounts and transactions have been eliminated.

(b) Inventories are stated at the lower of cost (first-in, first-out
basis) or market.

(c) Prepaid assets include product introduction expenses (which are
recorded at cost and amortized over the economic life thereof), but
not in excess of twelve months, consulting and other prepaids.

(d) Fixed assets are composed of manufacturing equipment, furniture,
office equipment, and computer equipment and are recorded at cost.
Depreciation is computed on a straight-line basis over the estimated useful
life, generally five years or less.

(e) Intangible assets, which are recorded at cost, are composed of debt
issuance costs, acquisition costs of Auburn Farms and Natures Warehouse
trademarks, and goodwill associated with the acquisition of Global
International Sourcing, Inc.  The acquisition costs associated with
trademarks and goodwill are being amortized on a straight-line basis over
twenty years.  All other intangible assets are being amortized on a straight-
line basis over periods not exceeding five years.  These costs are reviewed
by management periodically and written down to the value of the future
benefit expected to be derived.

(f) For the purpose of cash flow, the Company considers all highly liquid
investments purchased with an original maturity of three months or less to be
cash equivalents.
                                      10
<PAGE>


(g) For the nine months ended September 30, 1999, basic loss per share
has been computed using the weighted average number of common shares
outstanding during the period.  Dividends on cumulative preferred stock are
not material.

NOTE 3 - INVENTORIES

Inventories are stated at the lower of cost (first in, first out) or
market. Inventory consists of the following:

                                 September 30, 1999   December 31, 199
                                ------------------   -----------------

Finished goods	                       $ 320,457	   $ 118,524
Packaging and raw material	             199,292	      78,079
                                         ---------      ----------
                                         $ 519,749	   $ 196,603
                                          ========       =========

NOTE 4 - STOCKHOLDERS' EQUITY

During the nine month period ended September 30, 1999, the holders of
stock options to purchase 5,460,860 shares of stock exercised these options
as follows:

(a) 2,050,316 shares at prices ranging from $0.085 to $1.00 in settlement
of debts previously recorded as a liability.

(b) 788,500 shares at prices ranging from $0.085 to $0.40 in exchange for
services rendered.

(c) 386,187 shares at prices ranging from  $0.10 to $0.25 as prepayment
for future services to be rendered to the Company.

(d) 1,235,857 shares at $0.44 to convert the remaining convertible debt of
$ 543,775 owed to Terra Healthy Living, Ltd. Also, the Company issued
1,000,000 shares at prices ranging from $0.085 to $0.50 as added compensation
to various employees.

NOTE 5 - GOING CONCERN

The Company has prepared the financial statements included herewith
assuming that the Company will continue as a going concern.  Although the
Company raised additional capital in 1998, it has not generated sufficient
revenue-producing activity to sustain its operations. Accordingly, the
Company must realize a satisfactory level of profitability from its current
and future operations in order to remain a viable entity.  The Company's
auditors have included an explanatory paragraph in their report for the year
ended December 31, 1998 indicating there is substantial doubt regarding the
Company's ability to continue as a going concern.  The accompanying
consolidated financial statements do not include any adjustments that might
result from the outcome of any uncertainty.

                                        11
<PAGE>

NOTE 6 - LITIGATION

The Company is subject to pending claims and litigation, the most
significant of which are discussed below.

In December 1994, Lloyd Gauntt, who invested an aggregate of $75,000 in
certain of the Company's private placements, initiated an action in Superior
Court, Orange County, California against his stockbroker, two national
brokerage firms, several companies in which he had invested; and, certain of
those company's officers.  Included among the defendants were the Company and
its then Chief Executive Officer, Steve Westlund.  The complaint seeks
damages in an unspecified amount in excess of $500,000 and punitive damages
in an unspecified amount in excess of $5,000,000. The Court dismissed the
class action claims as to the Company and granted a motion that the claims
against the brokerage firms and associated persons must be submitted to
arbitration.   The Plaintiff appealed that ruling and the appellate court
affirmed the lower court ruling.  The Company denies any liability to the
plaintiff and intends to vigorously defend this action in the event the
plaintiff seeks to pursue the arbitration.  The Company notes that the
plaintiff sold a portion of the securities he purchased from the Company,
realizing a profit; that the balance of the securities became salable under
Rule 144; and that, if sold, the Plaintiff `s losses might be as little as
$15,000.

In April, 1997, the Company agreed in principle with ATCOLP INVESTMENT
PARTNERS, a California Limited Partnership (the "Lender), in which Donald
Wohl, a Director of the Company at the time, is the general partner, for a
loan in the amount of $300,000 (the "Loan"), to fund the payment of legal
fees in connection with the Company's arbitration against The Keebler
Company.   The loan was evidenced by a note which bears interest at the
lesser of 15% per annum or the highest rate allowed by law with recourse
solely to the net proceeds of the arbitration, if any.  If the Company did
not realize any net proceeds from the arbitration, the Loan would be canceled
and the Lender would receive a warrant for the purchase of 400,000 shares of
the Company's Common Stock at $.01 per share.  If the Loan was repaid through
the application of the net proceeds of the arbitration, the Lender would
receive warrants for the purchase of 200,000 shares of Common Stock at $.01
per share and a percentage of net proceeds of the arbitration equal to 15% of
the first $1,000,000 of net proceeds, but not less than $100,000; 20% of the
net proceeds greater than $1,000,000 and less than $3,000,000; and, 25% of
net proceeds above $3,000,000.  The Loan was approved by the disinterested
members of the Company's Board of Directors, and was on terms no less
favorable to the Company than were available from non-affiliated lenders.  A
second proposal, from another source, contained terms which would have
required the Company to pay $2,050,000 in fees based on the actual award,
repay the $300,000 advance, and be granted a warrant for 1,000,000 shares of
the Company's common stock at an exercise price of $1.00.  The loan amount of
$300,000 was repaid upon settlement of the litigation in June 1997 and
receipt of funds in July 1997, plus $1,236,883 in conformity with the agreed
upon formula, plus a warrant for 200,000 shares of the Company's common stock
at a $0.01 per share.



                                       12
<PAGE>


In connection with the acquisition of assets of Auburn Farms, Inc., ("AFI")
in 1996, the Company acquired the intellectual property and certain claims of
AFI.  In May 1996, the Company filed an action in federal court alleging
Lanham Act violations, misappropriation of trade secrets, unfair competition,
conspiracy and related claims arising out of misappropriation of Auburn
Farms' principal products by Auburn Farms co-packer, New Life Bakery
("New Life") and a principal competitor, Barbara's Bakery ("Barbara's").

On August 3, 1999, the Company entered into litigation settlement
agreements with Barbara's Bakery, Inc. ("Barbara's Bakery"), New Life Bakery,
Inc. ("New Life"), Gil Pritchard, David Marson, James Marson, and Kim Walters
(collectively the "Defendants") and resolved the Company's disputes with its
insurers over coverage for Defendants' counterclaims against the Company and
Mark Beychok.  The lawsuit alleged that Barbara's Bakery had violated the
Federal Lanham Act, and the California Unfair Competition Act, by improperly
marketing toaster pastries, fruit juice sweetened cookies, and fig bars, and
that New Life Bakery had breached an agreement with Auburn Farms, Inc., whose
claims Vitafort purchased in 1996.  Barbara's Bakery further agreed to
withdraw from the toaster pastry business by discontinuing its Nature's
Choice Toaster Pastry line by no later than November 30, 1999.  Vitafort had
secured up to $800,000 in off balance sheet financing for the litigation
against New Life and Barbara's Bakery, including $600,000 from an investment
partnership, Auburn Farms Vindication Partners, LLC, for the purpose of
paying the legal fees and expenses of the pending litigation.  The fee
arrangement included a limited, partial contingency arrangement with the
Chicago-based law firm of Jenner & Block.  After paying attorneys' fees and
making payments to outside investors who funded the litigation, the Company
will receive [has received ???] approximately $1,200,000.  Each party to the
litigation denies all liability and wrongdoing in connection with the claims
asserted in the pending litigation.  The Company intends to use the proceeds
of the settlement towards its working capital requirements.

In addition to the items discussed in this note, the Company is a party
to legal proceedings (which generally relate to disputes between the Company
and its suppliers or customers regarding payment for products sold or
supplied) are typical for a company of its size and scope and financial
condition, and that none of these proceedings are believed to be material to
its financial condition or results of operations.

ITEM 2.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL
CONDITION AS RESULTS OF OPERATIONS  (Unaudited)

Cautionary Statement for Purposes of "Safe Harbor Provisions" of the Private
Securities Litigation Reform Act of 1995:

Except for historical facts, all matters discussed in this report which are
forward looking involve a high degree of risks and uncertainties.  Potential
risks and uncertainties include, but are not limited to, competitive
pressures from other food companies and within the grocery industry, economic
conditions in the Company's primary markets and other uncertainties detailed
from time to time in the Company's Securities and Exchange Commission
filings.

                                      13
<PAGE>


Three Months and Nine Months Ended September 30, 1999 and 1998

Results of Operations:

In the third quarter, management achieved the objective that it had set
in the second quarter as critical issues to resolve in order to establish a
sound base for the launch of its new products.  First, the network of food
brokers was significantly improved with the appointment of Crossmark Sales
and Marketing in several markets in the Midwest, Southeast and Southwest
regions.  As such, the Company increased its broker representation to over
85% of U.S. markets.  At the beginning of the quarter, the broker coverage
for Vitafort's products was less than 35%.  Crossmark is one of the leading
brokerage companies in the food industry and will provide the Vitafort sales
team with the support needed to execute the upcoming distribution initiatives
of the new product introductions.

During the third quarter, the Company introduced its new "Peanut Squeeze"
line, as well as the repackaged "The Wizard of Oz" marshmallows and a new
white marshmallow, to ten major grocery and leading retail chains across the
country.  The initial reception of the product in the market place has been
positive and reorders have already been received from Wal-Mart and
other wholesalers.

The new sales force is aggressively continuing its presentations of
"Peanut Squeeze" and the repackaged marshmallows to supermarket chain buyers
and is generating new distribution.  The initial response to both the new
package design and the while marshmallow has been very positive, as the
Company recently shipped its initial orders to Albertsons and Save-mart.
Management feels the Company has a tremendous opportunity in this category
due to certain competitive advantages and market conditions, superior tasting
white marshmallow, unique shapes and flavors, "the Wizard of Oz" branded
strategy.  Management notes that the category leader recently filed for
bankruptcy protection under Chapter 11.

Management believes that, with the combined rollout of "Peanut Squeeze"
and "the Wizard of Oz," the Company will enjoy additional leverage and
attention from both its brokers and retailers.

Management believes that with the settlement of the Barbara's
litigation, the increased logistics efficiencies, the improved broker
representation and the continued rollout of the Company's two key product
lines (Peanut Squeeze and The Wizard of Oz), the Company will experience
significant increase in revenue in the upcoming months.  However, no
assurance can be given that difficulties will not be encountered and
increases will in fact occur.

Net Revenues:

	For the three months ended September 30, 1999, net sales were $738,437
compared to $805,511 for the same period in 1998, a decrease of $67,074, or
approximately 8%.  This decrease in revenue was due to delay in the
redesigning of the packaging for "The Wizard of Oz" marshmallows.

                                       14
<PAGE>


For the nine months ended September 30, 1999, net sales were $1,851,685
compared to $1,555,505 for the same period in 1998, an increase of $296,180
or 19%.  This was due primarily to sales of  "Peanut Squeeze" to new
distribution.

Gross Profit:

Gross profit decreased from $402,419 for the three months ended September 30,
1998 to $213,761 for the three months ended September 30, 1999, a decrease of
$188,658 or 47%.  Gross profit was 29% of net revenues for the quarter ended
September 30, 1999, compared to 50% for the same period of 1998.  This is due
to start-up costs incurred as a result of the launch of "Peanut Squeeze."

Gross profit increased from $604,098 for the nine months ended September
30, 1998 to $690,033 for the nine months ended September 30, 1999, an
increase of $85,935 or 14%.  The increase is due to the favorable mix of
selling marshmallows and "peanut squeeze' which have lower cost of goods
ratios.

Operating Expenses:

Research and Development - Total expenses for product development in the
three months ended September 30, 1999 were $34,159 compared to $140,667
for the same period in 1998, a decrease of $106,508 or 76%.  This is in line
with the Company's on-going strategy to source from existing manufacturers
and use their internal research and technical staff to develop the new
products.

Research and Development - Total expenses for product development in the nine
months ended September 30, 1999 were $56,315 compared to $280,251 for the
same period in 1998, a decrease of $223,936 or 80%.

Sales and Marketing:

Total sales and marketing expenses for the three months ended September
30, 1999 were $496,873 compared to $621,708 for the three months ended
September 30, 1998, a decrease of $124,835 or 20%.  This decrease in expenses
was primarily due to lower staffing costs and consultant expenses.

Total sales and marketing expenses for the nine months ended September
30, 1999 were $1,279,950 compared to $1,368,052 for the nine months ended
September 30, 1998, a decrease of $88,102 or 6%.

General and Administrative:

For the three months ended September 30, 1999, total general and administrative
expenses were $520,616 compared to $647,295 for the same quarter ended
September 30, 1998, a decrease of $126,679 or 20%.  Significant cost
reductions were primarily achieved in the following areas: wages, $74,000
due to reduction of staff;  consultants, $50,000; legal and accounting,
$15,000.



                                     15
<PAGE>


For the nine months ended September 30, 1999, total general and
administrative expenses were $1,394,384 compared to $2,121,026 for the same
period ended September 30, 1998, a decrease of $726,643 or 34%.  Significant
cost reductions were primarily achieved in the following areas: legal,
$468,691, due to off balance sheet financing of a litigation; consultants,
$290,810, as part of the cost reduction program.

Other Income (Expense):

The interest expenses decreased from $51,296 for the same period in 1998 to
$36,871 in the three months ended September 30, 1999, due to the forgiveness
of interest accrued on a note payable to Terra Healthy Living, Ltd.

Interest expenses increased from $149,202 for the same period in 1998 to
$253,723 for the nine months ended September 30, 1999.  This increase is
due to higher costs of lines of credit required to fund the Company's working
capital needs.

Other income was $1,636,147 for the three months ended September 30, 1999,
compared to $3,219 for the three months ended September 30, 1998.  The
increase of $1,632,928 is due to a partial forgiveness of debt by Terra
Healthy Living, Ltd. Of $1,521,225 of a note payable in the amount of
$2,065,000 and to additional forgiveness of payables to vendors.

Other income was $3,110,196 for the nine months ended September 30, 1999 is
due primarily to a litigation recovery from Barbara's Bakery of $1,260,632
and the forgiveness of debt by Terra Healthy Living, Ltd. In the
amount of $1,521,225.

Liquidity and Capital Resources:
<TABLE>
<CAPTION>
	      							   Nine Months Ended
									     September 30,
							              1999         1998
                                                   ---------    ------------
<S>                                              <C>           <C>
Net Cash Provided by Operations                  $  461,435    $  (2,938,595)
Net Cash Used In Investing Activities               104,058      	  (252,783)
Net Cash Provided by (Used in) Financing
  Activities                                       (142,109) 	  1,219,726
Working Capital (Deficit)                          (296,152) 	     55,407

The Company has introduced its new line of "Peanut Squeeze" as well as the
repackaged "The Wizard of Oz" marshmallows.  The initial reaction to these
products has been favorable, as new distribution is being achieved and
reorders have been received from existing customers.  However, there is no
guarantee that these products, once introduced in the market, will achieve
the anticipated level of sales forecast by the Company nor reach the gross
profit margin targeted by the Company for each of the products.  In addition,
while the Company's financial condition has improved over the past twelve


                                       16
<PAGE>


months, there is no guarantee that new co-packers will provide the Company
with credit terms.  Nor is there any assurance that the Company will be able
to meet its future cash obligations without additional external funding and
improved sales.  Neither additional financing nor improved sales can be
guaranteed to occur in the future.  While the Company has made significant
improvement in rebuilding customer relationships, the process has been slow
and costly, and there is no guarantee that these customers will purchase
products from the Company with the same enthusiasm that they have in the
past.

The Company continues to suffer recurring losses from operations as of
September 30, 1999 and  has not generated sufficient revenue-producing
activity to sustain its operations.  The Company's independent certified
public accountants have included a modification to their opinion, for the year
ended December 31, 1998 which indicates there is substantial doubt about the
Company's ability to continue as a going concern.  See "Note 5" to the
consolidated financial statements for additional information.  The Company is
attempting to raise additional capital to meet future working capital
requirements and launch new products, but may not be able to do so.  Should the
Company not be able to raise additional capital, it may have to curtail
operations.

PART II - OTHER INFORMATION

ITEM 1 - Legal Proceedings

In December 1994, Lloyd Gauntt, who invested an aggregate of $75,000 in
certain of the Company's private placements, initiated an action in Superior
Court, Orange County, California against his stockbroker, two national
brokerage firms, several companies in which he had invested; and, certain of
those company's officers.  Included among the defendants were the Company and
its then Chief Executive Officer, Steve Westlund.  The complaint seeks
damages in an unspecified amount in excess of $500,000 and punitive damages
in an unspecified amount in excess of $5,000,000. The Court dismissed the
class action claims as to the Company and granted a motion that the claims
against the brokerage firms and associated persons must be submitted to
arbitration.   The Plaintiff appealed that ruling and the appellate court
affirmed the lower court ruling.  The Company denies any liability to the
plaintiff and intends to vigorously defend this action in the event the
plaintiff seeks to pursue the arbitration.  The Company notes that the
plaintiff sold a portion of the securities he purchased from the Company,
realizing a profit; that the balance of the securities became salable under
Rule 144; and that, if sold, the Plaintiff `s losses might be as little as
$15,000.

In April, 1997, the Company agreed in principle with ATCOLP INVESTMENT
PARTNERS, a California Limited Partnership (the "Lender), in which Donald
Wohl, a Director of the Company at the time, is the general partner, for a
loan in the amount of $300,000 (the "Loan"), to fund the payment of legal
fees in connection with the Company's arbitration against The Keebler
Company.   The loan was evidenced by a note which bears interest at the
lesser of 15% per annum or the highest rate allowed by law with recourse

                                       17
<PAGE>


solely to the net proceeds of the arbitration, if any.  If the Company did
not realize any net proceeds from the arbitration, the Loan would be canceled
and the Lender would receive a warrant for the purchase of 400,000 shares of
the Company's Common Stock at $.01 per share.  If the Loan was repaid through
the application of the net proceeds of the arbitration, the Lender would
receive warrants for the purchase of 200,000 shares of Common Stock at $.01
per share and a percentage of net proceeds of the arbitration equal to 15% of
the first $1,000,000 of net proceeds, but not less than $100,000; 20% of the
net proceeds greater than $1,000,000 and less than $3,000,000; and, 25% of
net proceeds above $3,000,000.  The Loan was approved by the disinterested
members of the Company's Board of Directors, and was on terms no less
favorable to the Company than were available from non-affiliated lenders.  A
second proposal, from another source, contained terms which would have
required the Company to pay $2,050,000 in fees based on the actual award,
repay the $300,000 advance, and be granted a warrant for 1,000,000 shares of
the Company's common stock at an exercise price of $1.00.  The loan amount of
$300,000 was repaid upon settlement of the litigation in June 1997 and
receipt of funds in July 1997, plus $1,236,883 in conformity with the agreed
upon formula, plus a warrant for 200,000 shares of the Company's common stock
at a $0.01 per share.

In connection with the acquisition of assets of Auburn Farms, Inc., ("AFI")
in 1996, the Company acquired the intellectual property and certain claims of
AFI.  In May 1996, the Company filed an action in federal court alleging
Lanham Act violations, misappropriation of trade secrets, unfair competition,
conspiracy and related claims arising out of misappropriation of Auburn
Farms' principal products by Auburn Farms co-packer, New Life Bakery ("New
Life") and a principal competitor, Barbara's Bakery ("Barbara's").

On August 3, 1999, the Company entered into litigation settlement
agreements with Barbara's Bakery, Inc. ("Barbara's Bakery"), New Life Bakery,
Inc. ("New Life"), Gil Pritchard, David Marson, James Marson, and Kim Walters
(collectively the "Defendants") and resolved the Company's disputes with its
insurers over coverage for Defendants' counterclaims against the Company and
Mark Beychok.  The lawsuit alleged that Barbara's Bakery had violated the
Federal Lanham Act, and the California Unfair Competition Act, by improperly
marketing toaster pastries, fruit juice sweetened cookies, and fig bars, and
that New Life Bakery had breached an agreement with Auburn Farms, Inc., whose
claims Vitafort purchased in 1996.  Barbara's Bakery further agreed to
withdraw from the toaster pastry business by discontinuing its Nature's
Choice Toaster Pastry line by no later than November 30, 1999.  Vitafort had
secured up to $800,000 in off balance sheet financing for the litigation
against New Life and Barbara's Bakery, including $600,000 from an investment
partnership, Auburn Farms Vindication Partners, LLC, for the purpose of
paying the legal fees and expenses of the pending litigation.  The fee
arrangement included a limited, partial contingency arrangement with the
Chicago-based law firm of Jenner & Block.  After paying attorneys' fees and
making payments to outside investors who funded the litigation, the Company
will receive approximately $1,200,000.  Each party to the litigation denies
all liability and wrongdoing in connection with the claims asserted in the
pending litigation.  The Company intends to use the proceeds of the
settlement towards its working capital requirements.

                                     18
<PAGE>


In addition to the items discussed in this note, the Company is a party
to legal proceedings (which generally relate to disputes between the Company
and its suppliers or customers regarding payment for products sold or
supplied) are typical for a company of its size and scope and financial
condition, and that none of these proceedings are believed to be material to
its financial condition or results of operations.

ITEM 5 - Other Information

Effective September 13, 1999, pursuant to a Share Exchange and Reorganization
Agreement, the Company disposed all of the issued and outstanding shares of
Hollywood Partners, Inc. a California corporation ("Operating Company") that
previously operated as a wholly owned subsidiary of Vitafort International
Corporation.  In consideration of the shares of the Operating Company, the
Company received an aggregate of 5,000,000 shares of common stock form Hollywood
Partners.com, Inc. ("Hollywood"), a publicly traded Delaware corporation.  The
Operating Company is now a wholly owned subsidiary of Hollywood and Vitafort is
the majority stockholder of Hollywood, holding 62.5% of Hollywood's issued and
outstanding common stock.

                      VITAFORT INTERNATIONAL CORPORATION

                                   SIGNATURE


Pursuant to the requirements of the Securities Exchange Act of 1934, the
Company has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.


                       VITAFORT INTERNATIONAL CORPORATION
                                   (Company)





		                    /s/ Mark Beychok
                                  Mark Beychok
                              Chief Executive Officer


		                    /s/ Fred Rigaud
                                  Fred Rigaud
                            Acting Chief Financial Officer


Date:   November 15, 1999





                                        19

</TABLE>

<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM 10-Q
AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             JAN-01-1999
<PERIOD-END>                               SEP-30-1999
<CASH>                                       1,327,033
<SECURITIES>                                    55,000
<RECEIVABLES>                                  620,547
<ALLOWANCES>                                    82,106
<INVENTORY>                                    411,150
<CURRENT-ASSETS>                             2,972,368
<PP&E>                                         425,558
<DEPRECIATION>                                 323,039
<TOTAL-ASSETS>                               3,843,319
<CURRENT-LIABILITIES>                        3,252,117
<BONDS>                                              0
                                0
                                         11
<COMMON>                                        16,947
<OTHER-SE>                                     574,242
<TOTAL-LIABILITY-AND-EQUITY>                 3,843,317
<SALES>                                      1,851,685
<TOTAL-REVENUES>                             1,851,685
<CGS>                                        1,139,933
<TOTAL-COSTS>                                (372,713)
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             253,723
<INCOME-PRETAX>                                830,742
<INCOME-TAX>                                     (820)
<INCOME-CONTINUING>                            831,562
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   831,562
<EPS-BASIC>                                          0
<EPS-DILUTED>                                        0


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission